Skip to: Main Content Search Main Navigation Audience Navigation

Ohio University is open

Portion of West Union Street remains closed following multiple structure fire. More Information
 
Darlene Berryman, Ph.D., RD, LD

Professor, Executive Director of the Diabetes Institute

Applied Health and Wellness / HCOM Biomedical Sciences 
Konneker Research Center
740-593-9943 
berrymad@ohio.edu

 

Education:  Ph.D. Cornell University

Research Interest: Growth hormone action impacts adipose tissue deposition, metabolism and function.

 

The unifying theme of my scholarly work is obesity. Globally, my research efforts assess the nutritional and hormonal factors that impact adipose (fat) tissue and influence risk of obesity and diabetes.  More specifically, my recent efforts have targeted how growth hormone (GH) action impacts adipose tissue deposition, metabolism and function using various mouse lines with altered GH action generated in the laboratory of Dr. John Kopchick.  These mice are particularly interesting in obesity research as mice with reduced GH action are obese but relatively long-lived and insulin sensitive.  Thus, these mice offer a model in which obesity has been 'disconnected' from the deleterious health outcomes that normally accompany obesity.  Through this collaboration, my studies have evaluated body composition over lifespan, depot specific differences in fat tissue accumulation, unique secretory and cellular profiles of adipose tissue, and other factors that contribute to the progression of obesity to overt diabetes in these mice.

 

For more information on Dr. Berryman and her research, click HERE.

Darlene Berryman in the news:
HCOM News-Berryman to head-up Ohio University's newly formed Diabetes Institute
WOUB-New Discoveries in Obesity and Diabetes Research
OHIO Medicine-Diabetes Institute
Student Research